AXQ Capital’s Arvinas ARVN Stock Holding History

AXQ Capital’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,073	Closed	-$149K	–	992
2026 Q1	$149K	Buy	+14,073	New	+$174K	0.02%	808
2025 Q2	–	Sell	-43,898	Closed	-$308K	–	572
2025 Q1	$308K	Buy	+43,898	New	+$688K	0.12%	291

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's ARVN Position: Q2 2026 in Review

AXQ Capital sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 14,073 shares — an estimated $149K sold.

AXQ Capital first reported a position in ARVN in Q1 2025 and held it in 2 quarters. The position peaked at $308K in Q1 2025. 202 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

AXQ Capital reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 14,073 Arvinas shares in Q2 2026, an estimated $149K.
AXQ Capital first reported a position in Arvinas in Q1 2025 and held it in 2 quarters.
AXQ Capital's Arvinas position peaked at $308K in Q1 2025.
202 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.